Published by Josh White on 1st November 2024
(Sharecast News) - Ondine Biomedical announced a proposed minimum £8.5m fundraising through a placing and subscription of new shares on Friday, priced at 8.5p each, to support the US phase three clinical trial of its nasal photodisinfection system, 'Steriwave'.
URL: http://www.digitallook.com/dl/news/story/34664282/...